Luxist Web Search

Search results

1. Results From The WOW.Com Content Network

2. Acadia Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Acadia_Pharmaceuticals

   Total equity. US$699.14 million (2019) Number of employees. 570 (June 30, 2020) Website. acadia.com. Footnotes / references. [1] Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.

3. List of drugs granted breakthrough therapy designation

   en.wikipedia.org/wiki/List_of_drugs_granted...

   Amgen. non-small cell lung cancer with KRAS G12C mutation. Avapritinib. Blueprint Medicines Corp. granted for two indications: mast cell leukemia and advanced systemic mastocytosis. Belumosudil. Kadmon Pharmaceuticals. chronic graft-versus-host disease. Pembrolizumab.

4. Pimavanserin - Wikipedia

   en.wikipedia.org/wiki/Pimavanserin

   Pimavanserin was developed by Acadia Pharmaceuticals.. Pimavanserin is expected to improve the effectiveness and side effect profile of antipsychotics. [8] [9] [10] The results of a clinical trial examining the efficacy, tolerability and safety of adjunctive pimavanserin to risperidone and haloperidol were published in November 2012, and the results showed that pimavanserin potentiated the ...

5. Acadia Pharmaceuticals: Here's What You Should Know ... - AOL

   www.aol.com/news/2014-02-26-acadia...

   Acadia plans to file its novel compound for Parkinson's psychosis, or PDP, later this year, a move which Acadia Pharmaceuticals: Here's What You Should Know About Its Surging Shares Skip to main ...

6. Acadia Files Nuplazid Label Expansion; Analyst Sees ... - AOL

   www.aol.com/news/acadia-files-nuplazid-label...

   Acadia Pharmaceuticals Inc. (ACAD) has announced that it has filed a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to support a potential new indication ...

7. ACADIA Pharmaceuticals Added to NASDAQ Biotechnology Index

   www.aol.com/2013/05/20/acadia-pharmaceuticals...

   ACADIA Pharmaceuticals Added to NASDAQ Biotechnology Index SAN DIEGO--(BUSINESS WIRE)-- ACADIA Pharmaceuticals Inc. (NAS: ACAD) , a biopharmaceutical company focused on innovative treatments that ...

8. AC-262,536 - Wikipedia

   en.wikipedia.org/wiki/AC-262,536

   AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator (SARM). Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a K i of 5 nM, and no significant affinity for any other receptors tested.

9. ACADIA Pharmaceuticals Announces Expedited Path to NDA Filing ...

   www.aol.com/2013/04/11/acadia-pharmaceuticals...

   ACADIA Pharmaceuticals Announces Expedited Path to NDA Filing for Pimavanserin Following Meeting with FDA Single Pivotal Phase III -020 Study and Other Supportive Data Sufficient for Future NDA ...